417 related articles for article (PubMed ID: 12238241)
1. Endocrinology in intensive care medicine: new insights and therapeutic consequences.
Van den Berghe G
Verh K Acad Geneeskd Belg; 2002; 64(3):167-87; discussion 187-8. PubMed ID: 12238241
[TBL] [Abstract][Full Text] [Related]
2. The neuroendocrine response to stress is a dynamic process.
Van den Berghe G
Best Pract Res Clin Endocrinol Metab; 2001 Dec; 15(4):405-19. PubMed ID: 11800514
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the neuroendocrinology of critical illness.
Van den Berghe G
Eur J Endocrinol; 2000 Jul; 143(1):1-13. PubMed ID: 10870025
[TBL] [Abstract][Full Text] [Related]
4. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness.
van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192
[TBL] [Abstract][Full Text] [Related]
5. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.
Kauppila M; Koskinen P; Irjala K; Remes K; Viikari J
Bone Marrow Transplant; 1998 Aug; 22(4):331-7. PubMed ID: 9722067
[TBL] [Abstract][Full Text] [Related]
7. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Iranmanesh A; Veldhuis JD; Bouillon R
Clin Endocrinol (Oxf); 2002 May; 56(5):655-69. PubMed ID: 12030918
[TBL] [Abstract][Full Text] [Related]
8. Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone-secretagogues.
Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Gouwy S; Stockman W; Weekers F; Schetz M; Lauwers P; Bouillon R; Bowers CY
Clin Endocrinol (Oxf); 1997 Nov; 47(5):599-612. PubMed ID: 9425400
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.
Van den Berghe G; de Zegher F; Baxter RC; Veldhuis JD; Wouters P; Schetz M; Verwaest C; Van der Vorst E; Lauwers P; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Feb; 83(2):309-19. PubMed ID: 9467533
[TBL] [Abstract][Full Text] [Related]
10. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
[TBL] [Abstract][Full Text] [Related]
11. The hypothalamus-pituitary-thyroid axis in critical illness.
Mebis L; van den Berghe G
Neth J Med; 2009 Nov; 67(10):332-40. PubMed ID: 19915227
[TBL] [Abstract][Full Text] [Related]
12. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
[TBL] [Abstract][Full Text] [Related]
13. The neuroendocrine response to critical illness is a dynamic process.
Vanhorebeek I; Van den Berghe G
Crit Care Clin; 2006 Jan; 22(1):1-15, v. PubMed ID: 16399016
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and metabolic strategies to attenuate catabolism in critically ill patients.
Vanhorebeek I; Van den Berghe G
Curr Opin Pharmacol; 2004 Dec; 4(6):621-8. PubMed ID: 15525554
[TBL] [Abstract][Full Text] [Related]
15. Dynamic neuroendocrine responses to critical illness.
Van den Berghe G
Front Neuroendocrinol; 2002 Oct; 23(4):370-91. PubMed ID: 12381331
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone secretagogues in critical illness.
Van den Berghe G
Horm Res; 1999; 51 Suppl 3():21-8. PubMed ID: 10592440
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine pathobiology of chronic critical illness.
Van den Berghe G
Crit Care Clin; 2002 Jul; 18(3):509-28. PubMed ID: 12140911
[TBL] [Abstract][Full Text] [Related]
18. [Endocrine regulation in critically ill patients].
Wrede CE
Dtsch Med Wochenschr; 2010 Apr; 135(14):712-5. PubMed ID: 20358501
[TBL] [Abstract][Full Text] [Related]
19. Endocrine evaluation of patients with critical illness.
Van den Berghe G
Endocrinol Metab Clin North Am; 2003 Jun; 32(2):385-410. PubMed ID: 12800538
[TBL] [Abstract][Full Text] [Related]
20. Pituitary function in patients with newly diagnosed untreated systemic lupus erythematosus.
Köller MD; Templ E; Riedl M; Clodi M; Wagner O; Smolen JS; Luger A
Ann Rheum Dis; 2004 Dec; 63(12):1677-80. PubMed ID: 15082470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
